this piece corresponds to the legacy myPDB login in the form of a bootstrap modal, will likely retire-->

DIF

2-[2,6-DICHLOROPHENYL)AMINO]BENZENEACETIC ACID

DIF as free ligands, exist in 17 entries. Example includes: 3N8Y 4OJ4 1DVX

Find related ligands: Stereoisomers Similar ligands Chemical Structure Search

View summary at Ligand Expo



Chemical Component Summary

Name2-[2,6-DICHLOROPHENYL)AMINO]BENZENEACETIC ACID
Identifiers2-[2-[(2,6-dichlorophenyl)amino]phenyl]ethanoic acid
FormulaC14 H11 Cl2 N O2
Molecular Weight296.15 g/mol
TypeNON-POLYMER
Isomeric SMILESOC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl
InChIInChI=1S/C14H11Cl2NO2/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19/h1-7,17H,8H2,(H,18,19)
InChIKeyDCOPUUMXTXDBNB-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count30
Chiral Atom Count0
Chiral Atomsn/a
Bond Count31
Aromatic Bond Count12
Leaving Atomsn/a

Drug Info: DrugBank

DrugBank IDDB00586 Different stereochemistry
NameDiclofenac
Groups
  • approved
  • vet_approved
DescriptionA non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt. [PubChem]
Synonyms
  • [2-(2,6-dichloroanilino)phenyl]acetic acid
  • 2-((2,6-dichlorophenyl)amino)benzeneacetic acid
  • Diclofenac Acid
  • Diclofenaco
  • Diclofenacum
Salts
  • Diclofenac diethylamine
  • Diclofenac epolamine
  • Diclofenac potassium
  • Diclofenac sodium
Brand Names
  • Act Diclo-miso
  • Apo-diclo
  • Apo-diclo Rapide 50 Mg Tablets
  • Apo-diclo SR
  • Apo-diclofenac
Affected OrganismHumans and other mammals
IndicationFor the acute and chronic treatment of signs and symptoms of osteoarthritis and rheumatoid arthritis.
PharmacologyDiclofenac is an acetic acid nonsteroidal antiinflammatory drug (NSAID) with analgesic and antipyretic properties. Diclofenac is used to treat pain, dysmenorrhea, ocular inflammation, osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and actinic keratosis
Mechanism of actionThe antiinflammatory effects of diclofenac are believed to be due to inhibition of both leukocyte migration and the enzyme cylooxygenase (COX-1 and COX-2), leading to the peripheral inhibition of prostaglandin synthesis. As prostaglandins sensitize pain receptors, inhibition of their synthesis is responsible for the analgesic effects of diclofenac. Antipyretic effects may be due to action on the hypothalamus, resulting in peripheral dilation, increased cutaneous blood flow, and subsequent heat dissipation.
Route of administration
  • Intravenous
  • Ophthalmic
  • Oral
  • Rectal
  • Topical
Categories
  • Acids, Carbocyclic
  • Analgesics
  • Analgesics, Non-Narcotic
  • Anti-Inflammatory Agents
  • Anti-Inflammatory Agents, Non-Steroidal
ATC-Code
  • M01AB05
  • S01BC03
  • M01AB55
  • M02AA15
  • D11AX18
AHFS-Code
  • 28:08.04.08
  • 28:08.04.92
CAS number15307-86-5
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682